A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
- 13 July 2010
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 18 (1), 63-73
- https://doi.org/10.1016/j.ccr.2010.05.025
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cdk2 suppresses cellular senescence induced by the c-myc oncogeneNature, 2009
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- A gene-alteration profile of human lung cancer cell linesHuman Mutation, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Kras regulatory elements and exon 4A determine mutation specificity in lung cancerNature Genetics, 2008
- CDK inhibitors in cancer therapy: what is next?Trends in Pharmacological Sciences, 2008
- Cdk1 is sufficient to drive the mammalian cell cycleNature, 2007
- Mice thrive without Cdk4 and Cdk2Molecular Oncology, 2007
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006